NASDAQ:EPIX
$2.80
(
4.48%
)
Friday, 27th Jan 2023
ESSA Pharma Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.36 | $2.95 | Friday, 27th Jan 2023 EPIX stock ended at $2.80. This is 4.48% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 8.30% from a day low at $2.65 to a day high of $2.87. |
| 90 days | $2.29 | $4.34 | |
| 52 weeks | $1.40 | $10.99 |
Historical ESSA Pharma Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $2.67 | $2.87 | $2.65 | $2.80 | 234 498 |
| 2023-01-26 | $2.81 | $2.81 | $2.63 | $2.68 | 253 158 |
| 2023-01-25 | $2.84 | $2.93 | $2.74 | $2.75 | 466 715 |
| 2023-01-24 | $2.73 | $2.95 | $2.67 | $2.91 | 742 471 |
| 2023-01-23 | $2.63 | $2.82 | $2.58 | $2.73 | 279 098 |
| 2023-01-20 | $2.60 | $2.68 | $2.52 | $2.63 | 389 616 |
| 2023-01-19 | $2.54 | $2.65 | $2.50 | $2.63 | 474 331 |
| 2023-01-18 | $2.75 | $2.75 | $2.52 | $2.57 | 134 000 |
| 2023-01-17 | $2.75 | $2.78 | $2.62 | $2.68 | 323 100 |
| 2023-01-13 | $2.85 | $2.89 | $2.75 | $2.78 | 193 700 |
| 2023-01-12 | $2.72 | $2.90 | $2.66 | $2.84 | 852 600 |
| 2023-01-11 | $2.67 | $2.75 | $2.61 | $2.70 | 520 531 |
| 2023-01-10 | $2.84 | $2.84 | $2.65 | $2.68 | 449 547 |
| 2023-01-09 | $2.75 | $2.81 | $2.68 | $2.79 | 514 741 |
| 2023-01-06 | $2.62 | $2.77 | $2.52 | $2.71 | 413 000 |
| 2023-01-05 | $2.67 | $2.87 | $2.57 | $2.59 | 317 454 |
| 2023-01-04 | $2.55 | $2.69 | $2.45 | $2.69 | 284 795 |
| 2023-01-03 | $2.60 | $2.77 | $2.53 | $2.56 | 221 548 |
| 2022-12-30 | $2.59 | $2.59 | $2.36 | $2.52 | 170 374 |
| 2022-12-29 | $2.55 | $2.69 | $2.52 | $2.61 | 154 736 |
| 2022-12-28 | $2.57 | $2.63 | $2.42 | $2.52 | 143 867 |
| 2022-12-27 | $2.43 | $2.67 | $2.43 | $2.57 | 212 147 |
| 2022-12-23 | $2.35 | $2.47 | $2.29 | $2.42 | 80 793 |
| 2022-12-22 | $2.43 | $2.45 | $2.31 | $2.35 | 243 550 |
| 2022-12-21 | $2.50 | $2.61 | $2.39 | $2.39 | 297 403 |
| 2022-12-20 | $2.53 | $2.58 | $2.44 | $2.54 | 186 167 |
| 2022-12-19 | $2.70 | $2.74 | $2.44 | $2.55 | 258 549 |
| 2022-12-16 | $2.93 | $2.93 | $2.62 | $2.62 | 284 740 |
| 2022-12-15 | $2.96 | $2.96 | $2.76 | $2.84 | 303 250 |
| 2022-12-14 | $3.05 | $3.17 | $2.84 | $2.99 | 189 327 |
| 2022-12-13 | $3.48 | $3.48 | $3.10 | $3.16 | 181 869 |
| 2022-12-12 | $3.28 | $3.32 | $3.10 | $3.21 | 324 889 |
| 2022-12-09 | $3.40 | $3.50 | $3.20 | $3.25 | 169 917 |
| 2022-12-08 | $3.39 | $3.49 | $3.30 | $3.39 | 161 119 |
| 2022-12-07 | $3.33 | $3.45 | $3.30 | $3.34 | 84 711 |
| 2022-12-06 | $3.43 | $3.44 | $3.23 | $3.32 | 91 752 |
| 2022-12-05 | $3.59 | $3.65 | $3.38 | $3.47 | 89 730 |
| 2022-12-02 | $3.71 | $3.78 | $3.53 | $3.60 | 163 880 |
| 2022-12-01 | $3.70 | $3.92 | $3.54 | $3.75 | 112 217 |
| 2022-11-30 | $3.55 | $3.82 | $3.51 | $3.69 | 163 111 |
| 2022-11-29 | $3.31 | $3.59 | $3.27 | $3.54 | 2 023 116 |
| 2022-11-28 | $3.24 | $3.30 | $3.13 | $3.25 | 361 434 |
| 2022-11-25 | $3.14 | $3.34 | $3.11 | $3.20 | 528 172 |
| 2022-11-23 | $3.26 | $3.27 | $3.09 | $3.11 | 287 050 |
| 2022-11-22 | $3.23 | $3.26 | $3.03 | $3.19 | 442 977 |
| 2022-11-21 | $3.21 | $3.32 | $3.08 | $3.15 | 240 041 |
| 2022-11-18 | $3.42 | $3.50 | $3.20 | $3.25 | 137 737 |
| 2022-11-17 | $3.58 | $3.60 | $3.37 | $3.39 | 168 216 |
| 2022-11-16 | $3.98 | $3.98 | $3.56 | $3.70 | 210 551 |
| 2022-11-15 | $3.40 | $4.15 | $3.35 | $3.89 | 612 284 |
About ESSA Pharma Inc.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
